CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) - Dilution Analysis

S-3 filing: This is an S-3 filing for the resale of common stock issuable upon the exercise of warrants.

8-K filing: Creative Medical Technology Holdings, Inc. entered into warrant exercise inducement offer letters with holders of existing warrants to purchase 1,116,136 shares of common stock, who agreed to exercise their warrants at $3.75 per share, in exchange for new warrants to purchase 2,790,340 shares of common stock, resulting in gross proceeds of approximately $4.2 million. ($4.2M proceeds)

10-Q filing | 2.6M shares outstanding

S-3 filing: This S-3 filing registers 1,799,774 shares of common stock issuable upon the exercise of common stock purchase warrants issued in a private placement on March 6, 2025, for resale by selling stockholders.

10-K filing | 1.7M shares outstanding

8-K filing: Creative Medical Technology Holdings, Inc. entered into warrant exercise inducement offer letters with holders of existing warrants, who agreed to exercise 837,104 shares at $4.42 per share, in exchange for new warrants to purchase 1,674,208 shares of common stock. ($3.7M proceeds)

S-1 filing: This S-1 filing describes the possible resale of 837,104 shares of common stock issuable upon the exercise of warrants and a registered direct offering of 418,552 shares of common stock, and a concurrent private placement of warrants to purchase 837,104 shares of common stock, which were sold for aggregate gross proceeds of $1,850,000.

10-Q filing | 1.7M shares outstanding

8-K filing: Creative Medical Technology Holdings, Inc. closed a registered direct offering and concurrent private placement on October 23, 2024, selling 418,552 shares of common stock at $4.42 per share, and agreeing to issue warrants to purchase up to 837,104 shares of common stock at an exercise price of $4.42 per share. ($1.85M proceeds)

S-3 filing: Creative Medical Technology Holdings, Inc. is filing a registration statement on Form S-3 relating to the offering of securities with an aggregate offering price of up to $50,000,000.

10-Q filing | 1.3M shares outstanding

8-K filing: Creative Medical Technology Holdings, Inc. entered into a Securities Purchase Agreement with CEO Timothy Warbington, who purchased one share of newly designated Series B Preferred Stock for $100.00. ($0.0M proceeds)

10-Q filing | 1.3M shares outstanding

10-K filing | 1.4M shares outstanding

10-Q filing | 1.4M shares outstanding

10-Q filing | 1.4M shares outstanding

8-K filing: Stock split 1-for-10 | Outstanding: 14,076,238 → 1,407,623

10-Q filing | 14.1M shares outstanding

10-K filing | 14.1M shares outstanding

10-Q filing | 14.1M shares outstanding

10-Q filing | 14.1M shares outstanding

10-Q filing | 9.5M shares outstanding

S-3 filing: This prospectus relates to the possible resale from time to time of up to 22,666,668 shares of our common stock, par value $0.001 per share, which are held by, or may be issued to, the selling stockholders identified in this prospectus.

8-K filing: Creative Medical Technology Holdings, Inc. completed the sale of 2,991,669 shares of common stock, pre-funded warrants to purchase 4,563,887 shares of common stock, and accompanying warrants to purchase 15,111,112 shares of common stock at a combined offering price of $2.25 per share, resulting in gross proceeds of approximately $17,000,000. ($17.0M proceeds)

8-K filing: Creative Medical Technology Holdings, Inc. completed the sale of common stock, pre-funded warrants, and accompanying warrants to institutional investors for gross proceeds of approximately $17,000,000. ($17.0M proceeds)

RW filing: Creative Medical Technology Holdings, Inc. is withdrawing the registration statement because it no longer plans to consummate the offering of its securities described in the registration statement.

10-K filing | 6.5M shares outstanding

8-K filing: Creative Medical Technology Holdings, Inc. sold 3,875,000 shares of common stock and accompanying warrants at a combined price of $4.13 per share, resulting in gross proceeds of $16,003,750 before deductions. ($16.0M proceeds)

10-Q filing | 2.5M shares outstanding

10-Q filing | 768.5M shares outstanding

8-K filing: Creative Medical Technology Holdings, Inc. completed the sale of 15% Original Issue Discount Senior Notes to institutional investors and issued warrants to purchase common stock, with Roth Capital Partners acting as the placement agent.

10-Q filing | 1142.0M shares outstanding

10-K filing | 1136.5M shares outstanding

8-K filing: Creative Medical Technology Holdings, Inc. filed a Certificate of Amendment to the Certificate of Designation of the Company's Series A Preferred Stock, increasing the voting power of the Series A Preferred Stock to 1,000 votes per share from 30 votes per share.

8-K filing: Creative Medical Technology Holdings, Inc. completed the sale of 350,000 shares of Series B Preferred Stock and issued 1,500,000 shares of Common Stock as Commitment Shares to BHP Capital NY, Inc. ($0.35M proceeds)

10-Q filing | 577.1M shares outstanding

10-Q filing | 333.1M shares outstanding

10-Q filing | 144.9M shares outstanding

10-K filing | 59.8M shares outstanding